Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
about
Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South AfricaThe epidemiological impact of HIV antiretroviral therapy on malaria in children.The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in AsiaEfavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical TrialPaediatric HIV: Progress on Prevention, Treatment and CureEmerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaHigh levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.HIV Resistance with Correlation to PMTCT Regimen in HIV-Infected Infants in Northern Tanzania.HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany.Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naïve HIV-Infected Children in Mali.Moving forward with treatment options for HIV-infected children.HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.Antiretroviral Treatment and Resistance Patterns in HIV-Infected Children.High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.The pharmacological treatment of acute HIV infections in neonates.HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.Breastfeeding and the 2015 South African guidelines for prevention of mother-to-child transmission of HIV.Research gaps in neonatal HIV-related care.Antiretroviral therapy during the neonatal period.Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina FasoPropelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration
P2860
Q34785616-00380F84-A097-4F73-9A78-EC125DE7E55AQ35156697-3BEDADA4-1610-4593-93EF-B0B3C064E9A9Q35347170-5E91D967-0CB4-482D-B37F-FE77989F85C2Q36032235-6D3CFB3C-73FA-436A-8B02-42AEAF61FCF8Q36063912-CC476F26-6BD3-4440-99C2-338D22162E52Q36306986-D124CFC3-49DF-4195-8229-305A060A362AQ36395153-76AFA1A1-6CB9-4ECA-9B74-4D754148D5DCQ36669337-F66CC06A-EB4D-48E7-96EC-1208EDC110BCQ37062207-67A308BA-0CF1-405B-AF7B-84FCBD11CF64Q37410105-DCDE6AEA-DC3C-4FE6-8ABC-89D28CD4A38AQ38630228-4E9A4DD1-5CC8-46F5-B729-7D823DF81B70Q38694328-EEBBB343-74B4-444F-A510-483C5379C781Q38849814-2E642012-F17C-41BF-B910-AAA3D0915FEEQ38853723-F72BA3F7-EE54-4581-99C0-BA4A7AF334A0Q38913062-CE2A609B-6BCF-489E-BD67-B00EF05371BCQ38960646-0DBD37CB-69AB-4ECC-94C7-D0AFA8EB6249Q40063042-CFACE83B-9B26-468E-AECB-ECF22C422449Q40107759-0AB79AC2-4A74-434C-A101-5205DF647F4AQ40458484-0DCD2C82-582B-4138-94F0-29C1B459B3BEQ41026791-88B2C26B-BA9B-47A0-B1D7-A31ACDE7EAE6Q41600560-6C9DC205-3E7E-47AB-85B9-625EB6302F01Q41919022-724495C7-625C-47F3-9398-A53C25E79D9AQ41925424-CB813A0C-315C-44C0-9B38-52B55E763CD8Q41929466-FF3930E0-AFD5-4ADA-9353-C0329F7E8430Q45326130-BAA73C29-788C-4602-B209-ACED69123B7DQ47591909-B0412464-D338-4B34-9EBE-C4FD2AF9F523Q49617530-5DC61338-59F3-44CB-B41C-18B3320BABA1Q50568163-8E92229A-6DB5-4D0A-9854-1326695B7284Q53800268-B78E5C28-D567-4291-8B3F-CB6B6DE585A9Q53800271-AA4109DB-9D0F-4F32-8085-B27E54A4E851Q53801515-3DA4BB73-91CE-48B0-86E2-67AD72B49701Q56335908-6B9894F3-E303-468D-8303-72EBDF0F9812Q56969729-154045E8-1855-4C70-89C7-43CADE1E77CB
P2860
Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@ast
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@en
type
label
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@ast
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@en
prefLabel
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@ast
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@en
P2093
P2860
P50
P1433
P1476
Drug resistance among newly di ...... us antiretroviral prophylaxis.
@en
P2093
Gillian Hunt
Johanna Ledwaba
Karl-Günter Technau
Martina Penazzato
Sam Pickerill
Silvia Bertagnolio
Vivian Black
P2860
P304
P356
10.1097/QAD.0000000000000261
P407
P577
2014-07-01T00:00:00Z